• Explore /
  • Poster
  • / Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.

Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.

Abstract Poster

Authors

null

Ying Liu

Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

Ying Liu , Guangsen Han , Hongle Li , Yuzhou Zhao , Zhi Li , Jing Zhuang , Gangcheng Wang , Baodong Li , Jinbang Wang , Zhimeng Li , Qingxin Xia , Chengjuan Zhang , Juan Yu , Ke Li , Shuning Xu , Lei Qiao , Gaizhen Kuang , Danyang Li

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT03939962

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4036)

DOI

10.1200/JCO.2021.39.15_suppl.4036

Abstract #

4036

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Ying Liu

First Author: Gong-Rang Chen

First Author: Xiaodong Wang

First Author: Hongli Li